Pfizer

dnaindia | May 16, 2016

Drug major Pfizer Inc on Monday said it will acquire biopharmaceutical firm Anacor Pharmaceuticals for around $5.2 billion in an all-cash deal. Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of cash, of approximately $5.2 billion, Pfizer Inc said in a statement....

MedCity News | January 14, 2020

Digital health companies have caught the eye of prominent corporate VCs. But funding rounds aside, they’ve still struggled to gain traction in a risk-averse industry. Audience members at a panel during J.P. Morgan Healthcare asked, will it take a marriage of the technology and pharmaceutical industries for them to succeed? So many companies today aren’t just life science companies or technology companies. They’re some combination of the two, said Stacy Feld, head of Johns...

MedCity News | January 13, 2020

Healthcare analytics company Arcadia raised $29.5 million in new funding. The growth capital round was led by Cigna Ventures, with participation from past investors. Burlington, Massachusetts-based Arcadia integrates with more than 40 different electronic health record companies. It aggregates and analyzes records data to help hospitals and accountable care organizations meet metrics for value-based care. The company also develops tools to identify gaps in patient care and find ways to improve o...

mHealthIntelligence | January 13, 2020

Teladoc Health is looking to combine telehealth and telemedicine with a major acquisition announced over the weekend. The Texas-based developer of consumer-to-provider telehealth solutions is adding provider-to-provider services with its planned purchase of InTouch Health. Announced prior to the J.P. Morgan Healthcare conference this week in San Francisco, the $600 million deal shakes up the upper echelons of connected health and pushes the industry even further toward integrated, enterprise-lev...